Brief: Sensorion To Present New Data On OTOF Gene Therapy

Sensorion SA

01/02/2022 06:47

Feb 1 (Reuters) - Sensorion SA  ALSEN.PA :
    * SENSORION TO PRESENT NEW DATA ON OTOF GENE THERAPY AT THE
ASSOCIATION FOR RESEARCH IN OTOLARYNGOLOGY ARO 45TH ANNUAL
MIDWINTER MEETING
    * THE POSTER SHOWS PRECLINICAL PROOF OF CONCEPT DATA OF
OTOF-GT,
SENSORION’S DUAL VECTOR AAV GENE THERAPY PROGRAM FOR THE
TREATMENT OF CHILDREN BORN WITH HEARING LOSS CAUSED BY OTOFERLIN
DEFICIENCY (DFNB9)

Source text for Eikon:  ID:nBw2J1C1Ja 
Further company coverage:  ALSEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))